Navigation Links
Deep Brain Stimulation May Help in Early Stages of Parkinson's
Date:2/13/2013

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, Feb. 13 (HealthDay News) -- Deep brain stimulation has been used for years to help relieve motor problems in people with advanced Parkinson's. Now, new research finds that the procedure may also help people in earlier stages of the disease.

The treatment involves placing electrodes in specific parts of the brain.

"So far, all studies have dealt with patients who had very severe disease," explained senior study author Dr. Gunther Deuschl, chairman of neurology at University Medical Center Schleswig-Holstein in Kiel, Germany. "The present group . . . are well within the spectrum of disease severity which has been treated with medication only. The surprising result was that even at this stage, the patients had a much better outcome after two years than those who were treated with medication alone."

The report is published in the Feb. 14 issue of the New England Journal of Medicine.

Standard treatment for Parkinson's disease, a nervous system disorder marked by tremors and other movement problems, is a drug called L-dopa (Levodopa), which replaces depleted reserves of the neurotransmitter dopamine.

Unfortunately, long-term use of L-dopa can result in severe swings in motor function.

"After years of being on these drugs, patients develop ups and downs so the medication doesn't hold them for very long," said Dr. Carlos Singer, director of the Parkinson's disease and movement disorders division at the University of Miami Miller School of Medicine. "They're fine for two hours, then they're lousy for two hours, then they take another pill. It's like a yo-yo."

Deep brain stimulation came along in the 1990s and revolutionized treatment for such patients, said Singer, who was not involved with the study.

"By putting electrodes in certain specific areas of the brain and stimulating them continuously, you get them to have a smoother day," he explained.

Unlike previous studies, the current study enrolled 251 patients who had just started having mild fluctuations and were still responding fairly well to drugs.

After being randomly selected to be in one of two groups, one receiving medication alone and the other receiving medication plus deep brain stimulation, the researchers found that those who received the combination therapy actually did better.

Patients in the deep brain stimulation group experienced an improvement of 26 percent in their quality of life.

This, said Deuschl, was "the most impressive finding," although mobility was also improved in the combination group.

Participants receiving deep brain stimulation did have a higher rate of suicide (two in this group versus one in the medication-only group), though the researchers speculated that the people in the study may have started out with higher risk for suicide.

In any event, patients undergoing deep brain stimulation would need to be closely monitored for psychiatric symptoms, the study authors added.

An accompanying editorial called the study "one of the most rigorously conducted trials of neurostimulation," yet also pointed out some limitations.

For one thing, patients in the study were younger, healthier and less likely to be demented than most patients with Parkinson's disease.

And deep brain stimulation alleviated only some symptoms of the disease.

The procedure is widely available in the United States, said Singer, but is only approved -- and Medicare only covers it -- for more advanced patients.

Still, the findings suggest that "instead of waiting for patients to have very marked fluctuations, peaks and very deep valleys, [we] move in when the peaks and valleys are not that steep," Singer said.

"The data suggest that patients can safely, and with significantly better outcome, receive neurostimulation," said Deuschl. "We expect that the international guidelines will change at this point, and the patients will be offered neurostimulation at a much earlier time."

The study was partially funded by Medtronic, which makes deep brain stimulation products.

More information

Learn more about Parkinson's at the U.S. National Institutes of Health.

SOURCES: Gunther Deuschl, M.D., Ph.D., chairman, neurology, University Medical Center Schleswig-Holstein, Kiel, Germany; Carlos Singer, M.D., professor, neurology, and director, division of Parkinson's disease and movement disorders, University of Miami Miller School of Medicine; Feb. 14, 2013, New England Journal of Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. For some, deep brain stimulation brings lasting improvement in neuropathic pain
2. In some dystonia cases, deep brain therapy benefits may linger after device turned off
3. DAI provides potential imaging biomarker to indicate brain tumor response to RT
4. Imaging acute ischemic stroke patients brains did not lead to improved outcomes
5. New brain-test app
6. Dickkopf makes fountain of youth in the brain run dry
7. No increase in brain aneurysm rupture risk during pregnancy and delivery
8. Veterans with mild traumatic brain injury have brain abnormalities
9. Electrical Brain Stimulation Plus Drug Fights Depression: Study
10. Study of brain cooling and clot-busting drug therapy for stroke receives FDA OK to expand
11. MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Deep Brain Stimulation May Help in Early Stages of Parkinson's
(Date:3/28/2017)... ... March 28, 2017 , ... City trips ... (IBT World Travel Trends Report). As travelers visit both urban destinations, they are ... and prolonged sun exposure. In response, the outdoor industry has blurred the lines ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
(Date:3/28/2017)... Calif. (PRWEB) , ... March 28, 2017 , ... ... its leading physicians, Paul Yost, will begin serving as new board chair for ... this month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... In ... Self-Funding Success website has recently developed and published an informational resource that addresses ... created based on common inquiries the site’s team of third party administrator (TPA) ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon and well-known ... to offer the recently FDA-approved Obalon Balloon System to his patients. The Obalon ... Surgical’s already comprehensive list of weight-loss services. Dr. Liu is proud to ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. ... of directors: Christopher Gabrieli ... serve as chairman of the board of Akcea Therapeutics. ... of Forest Laboratories. Sandford D. Smith ... "We are excited to announce this expansion to ...
(Date:3/28/2017)... , March 28, 2017 ... expected to reach a value of USD 4.5 billion ... View Research, Inc. Proper closure of injured tissues post ... and function. Postoperative leakages occur in 3% to 15% ... They are responsible for one third of postoperative deaths ...
(Date:3/27/2017)... , March 27, 2017 The National ... health and data analytics company, signed a Memorandum ... improving healthcare delivery in the region. ... Global Health Research and Technology (BIGHEART) at NUS ... several topics related to healthcare IT and medical ...
Breaking Medicine Technology: